Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020)
Ocugen (OCGN) reported Other Accumulated Expenses of $9755.0 for Q4 2020, down 95.26% on a YoY basis from $205991.0 in Q1 2020, and down 95.1% quarter-over-quarter from $199261.0 in Q3 2020.
Ocugen (OCGN) Other Accumulated Expenses (2015 - 2020) Analysis & Trends
Ocugen has reported Other Accumulated Expenses for 6 years, with the latest figure at $9755.0 in Q4 2020.
- For the quarter ending Q4 2020, Other Accumulated Expenses fell 95.26% year-over-year to $9755.0; the trailing twelve-month figure through Dec 2020 stood at $9755.0 (down 95.26% YoY), and the FY2020 full-year result was $9755.0, down 95.26% from the prior year.
- Other Accumulated Expenses for Q4 2020 stood at $9755.0, down from $199261.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $632000.0 in Q4 2017, with the low at $9755.0 in Q4 2020.
- Historically, Other Accumulated Expenses has averaged $271315.5 across 5 years, with a median of $205425.5 in 2019.
- Annual changes were most pronounced in 2017 — Other Accumulated Expenses grew 24.41% — and 2020, when it sank 95.26%.
- Ocugen's Other Accumulated Expenses stood at $508000.0 in 2016, then gained by 24.41% to $632000.0 in 2017, then tumbled by 67.68% to $204242.0 in 2018, then increased by 0.86% to $205991.0 in 2019, then slumped by 95.26% to $9755.0 in 2020.
- The last three Other Accumulated Expenses figures came in at $9755.0 (Q4 2020), $199261.0 (Q3 2020), and $204860.0 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 9,755.00 |
| Sep 30, 2020 | 199,261.00 |
| Jun 30, 2020 | 204,860.00 |
| Mar 31, 2020 | 206,415.00 |
| Dec 31, 2019 | 205,991.00 |
| Dec 31, 2018 | 204,242.00 |
| Dec 31, 2017 | 632,000.00 |
| Dec 31, 2016 | 508,000.00 |
| Dec 31, 2015 | 548,000.00 |